United States Healthcare Providers & Services

Quest Diagnostics Inc (DGX)

Track

Over the last 90 days, Quest Diagnostics Inc. has seen significant insider selling activity, totaling over $5.5 million. Notably, officers and executives like J.E. Davis, Karthik Kuppusamy, Patrick Plewman, Catherine T. Doherty, and Michael E. Prevoznik have engaged in multiple proposed and planned sales, indicating a trend of divestment among key personnel.

Not featured in screeners

Featured in screeners

Not featured in screeners

Stock chart

Ticker: DGX Exchange: NYS

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Top insiders

Company data & Insiders

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Trades

KUPPUSAMY KARTHIK

SVP, Clinical Solutions

2 sales — total 200,000 USD

Planned sale 4 Jun 2026

Value US$939,895.51 | Price 439.01 | Shares 73,805

Proposed sale 4 Jun 2026

Value US$212,670.36 | Price 451.45 | Shares 19,287

Davis J. E.

CEO and President

2 sales — total 200,000 USD

Planned sale 1 Jun 2026

Value US$3,817,953.04 | Price 430.15 | Shares 10,202

Proposed sale 1 Jun 2026

Value US$3,677,778.76 | Price 295.52 | Shares 2,368

PREVOZNIK MICHAEL E

SVP & General Counsel

2 sales — total 1,599,365 USD

Planned sale 5 Mar 2026

Value US$799,682.38 | Price 206.21 | Shares 3,878

Proposed sale 5 Mar 2026

Value US$799,682.38 | Price 206.21 | Shares 3,878

Plewman Patrick

SVP for Diagnostic Services

2 sales — total 1,177,459 USD

Planned sale 5 Mar 2026

Value US$588,729.55 | Price 206.21 | Shares 2,855

Proposed sale 5 Mar 2026

Value US$588,729.55 | Price 206.21 | Shares 2,855

Doherty Catherine T.

EVP, Regional Businesses

2 sales — total 2,292,230 USD

Planned sale 5 Mar 2026

Value US$1,146,115.18 | Price 206.21 | Shares 5,558

Proposed sale 5 Mar 2026

Value US$1,146,115.18 | Price 206.21 | Shares 5,558

KUPPUSAMY KARTHIK

SVP, Clinical Solutions

1 sale — total 538,372 USD

Sale 4 Mar 2026

Value US$538,372.08 | Price 204.86 | Shares 2,628

PREVOZNIK MICHAEL E

SVP & General Counsel

2 sales — total 218,532 USD

Planned sale 3 Mar 2026

Value US$109,265.98 | Price 207.73 | Shares 526

Proposed sale 3 Mar 2026

Value US$109,265.98 | Price 207.73 | Shares 526

Doherty Catherine T.

EVP, Regional Businesses

2 sales — total 262,571 USD

Planned sale 3 Mar 2026

Value US$131,285.36 | Price 207.73 | Shares 632

Proposed sale 3 Mar 2026

Value US$131,285.36 | Price 207.73 | Shares 632

Plewman Patrick

SVP for Diagnostic Services

2 sales — total 170,339 USD

Planned sale 3 Mar 2026

Value US$85,169.30 | Price 207.73 | Shares 410

Proposed sale 3 Mar 2026

Value US$85,169.30 | Price 207.73 | Shares 410

Davis J. E.

CEO and President

2 sales — total 4,250,400 USD

Planned sale 2 Mar 2026

Value US$2,125,200.00 | Price 212.52 | Shares 10,000

Proposed sale 2 Mar 2026

Value US$2,125,200.00 | Price 212.52 | Shares 10,000

Plewman Patrick

SVP for Diagnostic Services

2 sales — total 392,454 USD

Planned sale 19 Feb 2026

Value US$196,227.14 | Price 204.83 | Shares 958

Proposed sale 19 Feb 2026

Value US$196,227.14 | Price 204.83 | Shares 958

PREVOZNIK MICHAEL E

SVP & General Counsel

2 sales — total 455,132 USD

Planned sale 19 Feb 2026

Value US$227,566.13 | Price 204.83 | Shares 1,111

Proposed sale 19 Feb 2026

Value US$227,566.13 | Price 204.83 | Shares 1,111

Doherty Catherine T.

EVP, Regional Businesses

2 sales — total 587,043 USD

Planned sale 19 Feb 2026

Value US$293,521.39 | Price 204.83 | Shares 1,433

Proposed sale 19 Feb 2026

Value US$293,521.39 | Price 204.83 | Shares 1,433

Doherty Catherine T.

EVP, Regional Businesses

6 sales — total 10,822,529 USD

Planned sale 13 Feb 2026

Value US$73,394.94 | Price 209.10 | Shares 351

Planned sale 13 Feb 2026

Value US$337,093.12 | Price 208.21 | Shares 1,619

Planned sale 13 Feb 2026

Value US$724,787.70 | Price 207.08 | Shares 3,500

Planned sale 13 Feb 2026

Value US$2,088,883.21 | Price 206.37 | Shares 10,122

Planned sale 13 Feb 2026

Value US$2,169,655.73 | Price 205.21 | Shares 10,573

Proposed sale 13 Feb 2026

Value US$5,428,714.20 | Price 207.48 | Shares 26,165

Plewman Patrick

SVP for Diagnostic Services

2 sales — total 2,310,096 USD

Planned sale 10 Feb 2026

Value US$1,155,048.00 | Price 204.00 | Shares 5,662

Proposed sale 10 Feb 2026

Value US$1,155,048.00 | Price 204.00 | Shares 5,662

Gregg Vicky B

2 sales — total 479,400 USD

Sale 25 Nov 2025

Value US$239,700.00 | Price 191.76 | Shares 1,250

Proposed sale 25 Nov 2025

Value US$239,700.00 | Price 191.76 | Shares 1,250

Davis J. E.

CEO and President

4 sales — total 21,179,521 USD

Planned sale 25 Nov 2025

Value US$916,036.66 | Price 192.97 | Shares 4,747

Planned sale 25 Nov 2025

Value US$7,883,900.59 | Price 192.27 | Shares 41,004

Planned sale 25 Nov 2025

Value US$1,789,822.57 | Price 191.59 | Shares 9,342

Proposed sale 25 Nov 2025

Value US$10,589,761.55 | Price 192.22 | Shares 55,093

DELANEY MARK E

SVP & Chief Commercial Officer

2 sales — total 2,977,366 USD

Planned sale 18 Nov 2025

Value US$1,488,683.10 | Price 187.35 | Shares 7,946

Proposed sale 18 Nov 2025

Value US$1,488,683.10 | Price 187.35 | Shares 7,946

PFEIFFER GARY M

2 sales — total 540,634 USD

Sale 22 Oct 2025

Value US$270,316.80 | Price 182.40 | Shares 1,482

Proposed sale 22 Oct 2025

Value US$270,316.80 | Price 182.40 | Shares 1,482

PREVOZNIK MICHAEL E

SVP & General Counsel

3 sales — total 85,412 USD

Planned sale 26 Sep 2025

Value US$27,166.77 | Price 188.66 | Shares 144

Planned sale 26 Sep 2025

Value US$15,539.24 | Price 187.22 | Shares 83

Proposed sale 26 Sep 2025

Value US$42,706.00 | Price 188.13 | Shares 227

PREVOZNIK MICHAEL E

SVP & General Counsel

2 sales — total 65,458 USD

Planned sale 24 Sep 2025

Value US$32,729.02 | Price 187.02 | Shares 175

Proposed sale 24 Sep 2025

Value US$32,729.03 | Price 187.02 | Shares 175

PREVOZNIK MICHAEL E

SVP & General Counsel

2 sales — total 10,586,626 USD

Planned sale 23 Sep 2025

Value US$5,293,312.79 | Price 187.12 | Shares 28,288

Proposed sale 23 Sep 2025

Value US$5,293,313.43 | Price 187.12 | Shares 28,288

Plewman Patrick

SVP for Diagnostic Services

2 sales — total 730,750 USD

Planned sale 21 Aug 2025

Value US$365,375.00 | Price 185.00 | Shares 1,975

Proposed sale 21 Aug 2025

Value US$365,375.00 | Price 185.00 | Shares 1,975

Plewman Patrick

SVP for Diagnostic Services

2 sales — total 1,658,712 USD

Planned sale 19 Aug 2025

Value US$829,356.00 | Price 183.00 | Shares 4,532

Proposed sale 19 Aug 2025

Value US$829,356.00 | Price 183.00 | Shares 4,532

Plewman Patrick

SVP for Diagnostic Services

3 sales — total 711,000 USD

Planned sale 15 Aug 2025

Value US$355,500.00 | Price 180.00 | Shares 1,975

Proposed sale 15 Aug 2025

Value US$12,960.00 | Price 180.00 | Shares 72

Proposed sale 15 Aug 2025

Value US$342,540.00 | Price 180.00 | Shares 1,903

Plewman Patrick

SVP for Diagnostic Services

3 sales — total 1,937,250 USD

Planned sale 6 Aug 2025

Value US$345,625.00 | Price 175.00 | Shares 1,975

Planned sale 6 Aug 2025

Value US$623,000.00 | Price 175.00 | Shares 3,560

Proposed sale 6 Aug 2025

Value US$968,625.00 | Price 175.00 | Shares 5,535

KUPPUSAMY KARTHIK

SVP, Clinical Solutions

2 sales — total 751,400 USD

Planned sale 31 Jul 2025

Value US$375,700.00 | Price 170.00 | Shares 2,210

Proposed sale 31 Jul 2025

Value US$375,700.00 | Price 170.00 | Shares 2,210

KUPPUSAMY KARTHIK

SVP, Clinical Solutions

3 sales — total 2,768,461 USD

Planned sale 30 Jul 2025

Value US$874,497.60 | Price 167.40 | Shares 5,224

Planned sale 30 Jul 2025

Value US$509,733.00 | Price 167.40 | Shares 3,045

Proposed sale 30 Jul 2025

Value US$1,384,230.60 | Price 167.40 | Shares 8,269

DELANEY MARK E

SVP & Chief Commercial Officer

2 sales — total 306,442 USD

Planned sale 13 May 2025

Value US$153,220.94 | Price 175.31 | Shares 874

Proposed sale 13 May 2025

Value US$153,220.94 | Price 175.31 | Shares 874

DELANEY MARK E

SVP & Chief Commercial Officer

2 sales — total 307,159 USD

Planned sale 12 May 2025

Value US$153,579.28 | Price 175.72 | Shares 874

Proposed sale 12 May 2025

Value US$153,579.28 | Price 175.72 | Shares 874

Davis J. E.

CEO and President

6 sales — total 749,436 USD

Planned sale 2 Apr 2025

Value US$76,844.20 | Price 169.63 | Shares 453

Planned sale 2 Apr 2025

Value US$152,249.48 | Price 168.79 | Shares 902

Planned sale 2 Apr 2025

Value US$250,642.75 | Price 167.88 | Shares 1,493

Planned sale 2 Apr 2025

Value US$45,282.45 | Price 169.60 | Shares 267

Planned sale 2 Apr 2025

Value US$98,520.27 | Price 168.70 | Shares 584

Planned sale 2 Apr 2025

Value US$125,897.10 | Price 167.86 | Shares 750

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2026-06-08	2026-06-04	PlS Planned sale	2.2 KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer	73,805 -36.0% 439.01 US$939,896	73,805 -36.0%	439.01	US$939,896
2026-06-04	2026-06-04	PrS Proposed sale	2.2 KUPPUSAMY KARTHIK Officer Officer	19,287 451.45 US$212,670	19,287	451.45	US$212,670
2026-06-02	2026-06-01	PlS Planned sale	Davis J. E. CEO and President Executive Director	10,202 -3.1% 430.15 US$3,817,953	10,202 -3.1%	430.15	US$3,817,953
2026-06-01	2026-06-01	PrS Proposed sale	Davis J. E. Officer; Director Executive Director	1,000 194.14 US$100,000	1,000	194.14	US$100,000
2026-03-06	2026-03-05	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	3,878 -9.4% 206.21 US$799,682	3,878 -9.4%	206.21	US$799,682
2026-03-06	2026-03-05	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	2,855 -15.8% 206.21 US$588,730	2,855 -15.8%	206.21	US$588,730
2026-03-06	2026-03-05	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	5,558 -7.6% 206.21 US$1,146,115	5,558 -7.6%	206.21	US$1,146,115
2026-03-05	2026-03-05	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	3,878 206.21 US$799,682	3,878	206.21	US$799,682
2026-03-05	2026-03-05	PrS Proposed sale	1.5 Doherty Catherine T. Officer Officer	5,558 206.21 US$1,146,115	5,558	206.21	US$1,146,115
2026-03-05	2026-03-05	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	2,855 206.21 US$588,730	2,855	206.21	US$588,730
2026-03-06	2026-03-04	S Sale	2.2 KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer	2,628 -16.4% 204.86 US$538,372	2,628 -16.4%	204.86	US$538,372
2026-03-04	2026-03-03	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	526 -1.4% 207.73 US$109,266	526 -1.4%	207.73	US$109,266
2026-03-04	2026-03-03	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	632 -0.9% 207.73 US$131,285	632 -0.9%	207.73	US$131,285
2026-03-04	2026-03-03	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	410 -2.6% 207.73 US$85,169	410 -2.6%	207.73	US$85,169
2026-03-03	2026-03-03	PrS Proposed sale	1.5 Doherty Catherine T. Officer Officer	632 207.73 US$131,285	632	207.73	US$131,285
2026-03-03	2026-03-03	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	526 207.73 US$109,266	526	207.73	US$109,266
2026-03-03	2026-03-03	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	410 207.73 US$85,169	410	207.73	US$85,169
2026-03-04	2026-03-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	10,000 -7.9% 212.52 US$2,125,200	10,000 -7.9%	212.52	US$2,125,200
2026-03-02	2026-03-02	PrS Proposed sale	Davis J. E. Officer; Director Executive Director	10,000 212.52 US$2,125,200	10,000	212.52	US$2,125,200
2026-02-20	2026-02-19	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	958 -5.7% 204.83 US$196,227	958 -5.7%	204.83	US$196,227
2026-02-20	2026-02-19	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	1,111 -2.8% 204.83 US$227,566	1,111 -2.8%	204.83	US$227,566
2026-02-20	2026-02-19	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	1,433 -2.1% 204.83 US$293,521	1,433 -2.1%	204.83	US$293,521
2026-02-19	2026-02-19	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	958 204.83 US$196,227	958	204.83	US$196,227
2026-02-19	2026-02-19	PrS Proposed sale	1.5 Doherty Catherine T. Officer Officer	1,433 204.83 US$293,521	1,433	204.83	US$293,521
2026-02-19	2026-02-19	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	1,111 204.83 US$227,566	1,111	204.83	US$227,566
2026-02-17	2026-02-13	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	351 -0.5% 209.10 US$73,395	351 -0.5%	209.10	US$73,395
2026-02-17	2026-02-13	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	1,619 -2.3% 208.21 US$337,093	1,619 -2.3%	208.21	US$337,093
2026-02-17	2026-02-13	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	3,500 -4.8% 207.08 US$724,788	3,500 -4.8%	207.08	US$724,788
2026-02-17	2026-02-13	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	10,122 -12.1% 206.37 US$2,088,883	10,122 -12.1%	206.37	US$2,088,883
2026-02-17	2026-02-13	PlS Planned sale	1.5 Doherty Catherine T. EVP, Regional Businesses Officer	10,573 -11.2% 205.21 US$2,169,656	10,573 -11.2%	205.21	US$2,169,656
2026-02-13	2026-02-13	PrS Proposed sale	1.5 Doherty Catherine T. Officer Officer	26,165 207.48 US$5,428,714	26,165	207.48	US$5,428,714
2026-02-12	2026-02-10	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	5,662 -26.9% 204.00 US$1,155,048	5,662 -26.9%	204.00	US$1,155,048
2026-02-10	2026-02-10	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	5,662 204.00 US$1,155,048	5,662	204.00	US$1,155,048
2025-11-28	2025-11-25	S Sale	2.6 Gregg Vicky B Non-Executive Director	1,250 -6.8% 191.76 US$239,700	1,250 -6.8%	191.76	US$239,700
2025-11-28	2025-11-25	PlS Planned sale	Davis J. E. CEO and President Executive Director	4,747 -3.8% 192.97 US$916,037	4,747 -3.8%	192.97	US$916,037
2025-11-28	2025-11-25	PlS Planned sale	Davis J. E. CEO and President Executive Director	41,004 -24.7% 192.27 US$7,883,901	41,004 -24.7%	192.27	US$7,883,901
2025-11-28	2025-11-25	PlS Planned sale	Davis J. E. CEO and President Executive Director	9,342 -5.3% 191.59 US$1,789,823	9,342 -5.3%	191.59	US$1,789,823
2025-11-25	2025-11-25	PrS Proposed sale	Davis J. E. Officer; Director Executive Director	55,093 192.22 US$10,589,762	55,093	192.22	US$10,589,762
2025-11-25	2025-11-25	PrS Proposed sale	2.6 Gregg Vicky B Director Non-Executive Director	1,250 191.76 US$239,700	1,250	191.76	US$239,700
2025-11-20	2025-11-18	PlS Planned sale	2.9 DELANEY MARK E SVP & Chief Commercial Officer Officer	7,946 -51.3% 187.35 US$1,488,683	7,946 -51.3%	187.35	US$1,488,683
2025-11-18	2025-11-18	PrS Proposed sale	2.9 DELANEY MARK E Officer Officer	7,946 187.35 US$1,488,683	7,946	187.35	US$1,488,683
2025-10-24	2025-10-22	S Sale	0.9 PFEIFFER GARY M Non-Executive Director	1,482 -4.8% 182.40 US$270,317	1,482 -4.8%	182.40	US$270,317
2025-10-22	2025-10-22	PrS Proposed sale	0.9 PFEIFFER GARY M Director Non-Executive Director	1,482 182.40 US$270,317	1,482	182.40	US$270,317
2025-09-30	2025-09-26	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	144 -0.4% 188.66 US$27,167	144 -0.4%	188.66	US$27,167
2025-09-30	2025-09-26	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	83 -0.2% 187.22 US$15,539	83 -0.2%	187.22	US$15,539
2025-09-26	2025-09-26	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	227 188.13 US$42,706	227	188.13	US$42,706
2025-09-25	2025-09-24	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	175 -0.5% 187.02 US$32,729	175 -0.5%	187.02	US$32,729
2025-09-24	2025-09-24	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	175 187.02 US$32,729	175	187.02	US$32,729
2025-09-25	2025-09-23	PlS Planned sale	2.7 PREVOZNIK MICHAEL E SVP & General Counsel Officer	28,288 -42.6% 187.12 US$5,293,313	28,288 -42.6%	187.12	US$5,293,313
2025-09-23	2025-09-23	PrS Proposed sale	2.7 PREVOZNIK MICHAEL E Officer Officer	28,288 187.12 US$5,293,313	28,288	187.12	US$5,293,313
2025-08-25	2025-08-21	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	1,975 -11.5% 185.00 US$365,375	1,975 -11.5%	185.00	US$365,375
2025-08-21	2025-08-21	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	1,975 185.00 US$365,375	1,975	185.00	US$365,375
2025-08-21	2025-08-19	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	4,532 -20.8% 183.00 US$829,356	4,532 -20.8%	183.00	US$829,356
2025-08-19	2025-08-19	PrS Proposed sale	1.5 Plewman Patrick Director Non-Executive Director	4,532 183.00 US$829,356	4,532	183.00	US$829,356
2025-08-19	2025-08-15	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	1,975 -10.3% 180.00 US$355,500	1,975 -10.3%	180.00	US$355,500
2025-08-15	2025-08-15	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	72 180.00 US$12,960	72	180.00	US$12,960
2025-08-15	2025-08-15	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	1,903 180.00 US$342,540	1,903	180.00	US$342,540
2025-08-08	2025-08-06	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	1,975 -9.3% 175.00 US$345,625	1,975 -9.3%	175.00	US$345,625
2025-08-08	2025-08-06	PlS Planned sale	1.5 Plewman Patrick SVP for Diagnostic Services Officer	3,560 -14.4% 175.00 US$623,000	3,560 -14.4%	175.00	US$623,000
2025-08-06	2025-08-06	PrS Proposed sale	1.5 Plewman Patrick Officer Officer	5,535 175.00 US$968,625	5,535	175.00	US$968,625
2025-08-01	2025-07-31	PlS Planned sale	2.2 KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer	2,210 -20.7% 170.00 US$375,700	2,210 -20.7%	170.00	US$375,700
2025-07-31	2025-07-31	PrS Proposed sale	2.2 KUPPUSAMY KARTHIK Officer Officer	2,210 170.00 US$375,700	2,210	170.00	US$375,700
2025-08-01	2025-07-30	PlS Planned sale	2.2 KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer	5,224 -32.9% 167.40 US$874,498	5,224 -32.9%	167.40	US$874,498
2025-08-01	2025-07-30	PlS Planned sale	2.2 KUPPUSAMY KARTHIK SVP, Clinical Solutions Officer	3,045 -22.2% 167.40 US$509,733	3,045 -22.2%	167.40	US$509,733
2025-07-30	2025-07-30	PrS Proposed sale	2.2 KUPPUSAMY KARTHIK Officer Officer	8,269 167.40 US$1,384,231	8,269	167.40	US$1,384,231
2025-05-14	2025-05-13	PlS Planned sale	2.9 DELANEY MARK E SVP & Chief Commercial Officer Officer	874 -10.4% 175.31 US$153,221	874 -10.4%	175.31	US$153,221
2025-05-13	2025-05-13	PrS Proposed sale	2.9 DELANEY MARK E Officer Officer	874 175.31 US$153,221	874	175.31	US$153,221
2025-05-14	2025-05-12	PlS Planned sale	2.9 DELANEY MARK E SVP & Chief Commercial Officer Officer	874 -9.5% 175.72 US$153,579	874 -9.5%	175.72	US$153,579
2025-05-12	2025-05-12	PrS Proposed sale	2.9 DELANEY MARK E Officer Officer	874 175.72 US$153,579	874	175.72	US$153,579
2025-04-04	2025-04-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	453 -0.4% 169.63 US$76,844	453 -0.4%	169.63	US$76,844
2025-04-04	2025-04-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	902 -0.7% 168.79 US$152,249	902 -0.7%	168.79	US$152,249
2025-04-04	2025-04-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	1,493 -1.1% 167.88 US$250,643	1,493 -1.1%	167.88	US$250,643
2025-04-04	2025-04-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	267 -0.2% 169.60 US$45,282	267 -0.2%	169.60	US$45,282
2025-04-04	2025-04-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	584 -0.4% 168.70 US$98,520	584 -0.4%	168.70	US$98,520
2025-04-04	2025-04-02	PlS Planned sale	Davis J. E. CEO and President Executive Director	750 -0.6% 167.86 US$125,897	750 -0.6%	167.86	US$125,897